Insider filing · GALT
Khurram Jamil
Chief Medical Officer
profile →
Galectin Therapeutics Inc.
GALT · Healthcare · 14 filings in 24 months
ticker →
Khurram Jamil sold $574K of Galectin Therapeutics (GALT)
Executed Nov 13 2025, disclosed Nov 14 2025, 1 day later.
Value, as filed
$574K
104,867 sh across 3 lots
Executed
Nov 13 2025
the trade date, as filed
Disclosed
Nov 14 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
KJKhurram Jamil (Chief Medical Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Galectin Therapeutics Inc. (GALT). The largest single filing was $574K of GALT (104,867 sh across 3 lots, as filed), executed Nov 13 2025.
The name
GALTHealthcare · Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in drug development to create new therapies for fibrotic di…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Khurram Jamil in GALT
GALTSALE
Galectin Therapeutics Inc.
$239K47,467 sh × $5.04
Exec Jun 29
Filed Jun 30 · 5:30 PM ET